Shares of Healthpeak Properties, Inc. (NYSE:DOC – Get Free Report) have been given a consensus rating of “Hold” by the nineteen analysts that are currently covering the stock, Marketbeat.com reports. Fifteen investment analysts have rated the stock with a hold recommendation and four have assigned a buy recommendation to the company. The average 1 year price target among analysts that have updated their coverage on the stock in the last year is $21.4412.
DOC has been the topic of a number of recent analyst reports. Wall Street Zen upgraded shares of Healthpeak Properties from a “sell” rating to a “hold” rating in a research note on Sunday, May 10th. Cantor Fitzgerald lifted their price target on Healthpeak Properties from $20.00 to $23.00 and gave the stock a “neutral” rating in a research note on Thursday, August 6th. Evercore downgraded Healthpeak Properties from an “outperform” rating to an “in-line” rating and set a $21.00 price target for the company. in a research note on Monday, May 11th. Scotiabank boosted their price objective on Healthpeak Properties from $19.00 to $21.00 and gave the company a “sector perform” rating in a report on Wednesday, May 27th. Finally, UBS Group upped their price objective on Healthpeak Properties from $19.00 to $21.50 and gave the company a “neutral” rating in a research note on Wednesday, July 8th.
Get Our Latest Analysis on Healthpeak Properties
Institutional Investors Weigh In On Healthpeak Properties
Healthpeak Properties Stock Up 0.7%
Shares of NYSE:DOC opened at $20.80 on Tuesday. The company has a current ratio of 3.02, a quick ratio of 3.02 and a debt-to-equity ratio of 1.06. The company has a fifty day simple moving average of $21.31 and a 200 day simple moving average of $18.89. The firm has a market cap of $14.35 billion, a PE ratio of 59.44, a price-to-earnings-growth ratio of 3.18 and a beta of 1.01. Healthpeak Properties has a 12-month low of $15.70 and a 12-month high of $22.95.
Healthpeak Properties (NYSE:DOC – Get Free Report) last posted its quarterly earnings results on Tuesday, August 4th. The real estate investment trust reported $0.08 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.03 by $0.05. Healthpeak Properties had a net margin of 8.24% and a return on equity of 2.79%. The firm had revenue of $771.58 million for the quarter, compared to analysts’ expectations of $725.64 million. During the same period in the prior year, the company posted $0.46 earnings per share. The firm’s quarterly revenue was up 11.1% on a year-over-year basis. Healthpeak Properties has set its FY 2026 guidance at 1.730-1.770 EPS. On average, equities research analysts anticipate that Healthpeak Properties will post 1.77 EPS for the current fiscal year.
Healthpeak Properties Dividend Announcement
The company also recently declared a monthly dividend, which will be paid on Friday, September 25th. Stockholders of record on Monday, September 14th will be issued a $0.1017 dividend. This represents a c) dividend on an annualized basis and a dividend yield of 5.9%. The ex-dividend date is Monday, September 14th. Healthpeak Properties’s payout ratio is 348.57%.
About Healthpeak Properties
Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.
Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.
Featured Stories
- Five stocks we like better than Healthpeak Properties
- Asian Market Circuit Breakers Hit Stocks, Not AI Demand
- Riot Platforms Re-Wires the Ledger for a $9B AI Power Play
- Nebius Just Exploded 34% on Blowout Earnings—Is It Time to Buy?
- Joby’s Defense Pivot Accelerates With $500M Resonant Sciences Deal
Receive News & Ratings for Healthpeak Properties Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthpeak Properties and related companies with MarketBeat.com's FREE daily email newsletter.
